INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM

Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properti...

Full description

Saved in:
Bibliographic Details
Published in:Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții 2017-01, Vol.27 (1), p.39-46
Main Authors: Ghafil, Firas, Anuta, Valentina, Sarbu, Iulian, Toderescu, Corina Dalia, Mircioiu, Ion
Format: Article
Language:English
Subjects:
Bioavailability
Chromatography
Classification
Controlled release
Dissolution
Drug delivery systems
Experiments
High-performance liquid chromatography
International conferences
Intestine
Mebendazole
Methods
Pharmaceutical industry
Quantitative analysis
Sodium
Tablets
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page 46
container_issue 1
container_start_page 39
container_title Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții
container_volume 27
creator Ghafil, Firas
Anuta, Valentina
Sarbu, Iulian
Toderescu, Corina Dalia
Mircioiu, Ion
description Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properties were prepared. For the quantitative assay of mebendazole a HPLC-UV method was developed and validated. Bioavailability was estimated by means of the in-vitro release kinetics using USP Apparatus 2, in Fasting State Simulated Intestinal Fluid (FaSSIF). Release of mebendazole in FaSSIF was poor (less than 10 % within 2 hours). Dissolution could be described by Higuchi law and Peppas law in both the swelling phase and post-errosion-disintegration phase, suggesting a diffusion controlled release. Both rate and extent of release increased with concentration of croscarmellose predicting a better bioavailability of mebendazole from the croscarmellose containing tablets.Keywords: mebendazole, croscarmellose, in vitro release, FaSSIF, intestinal suprasaturation
format article
fullrecord <record><control><sourceid>proquest</sourceid><recordid>TN_cdi_proquest_journals_2091279301</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2091279301</sourcerecordid><originalsourceid>FETCH-LOGICAL-p98t-74cef09b68b6e27cd24299436893abfb17959b2becf49c398d17714e60bb08163</originalsourceid><addsrcrecordid>eNotjc1OwzAQhCMEElXpO1jiSlD809g-uonTruQ4Uuwg4FLVaXKoEC1N-yy8Lkawl5ndGX17k8ywYCTlMqe30S8FSwnN6X2ymKZDFodKIjmbJd9gi1YrB3aN_EajFTTqRRkwagUG_BtqKlTrlbalem-MRgDPCGxlOm0L_RsWbeMK1dbamMbFi0UlONeYzkP0rfL6CelXr61HypaRVWyUBVdHCnJQdyY2yrh47TxYZWKjhK5-SO7G3cc0LP51nvhK-2KTmmYNhTLpSYpLylk_jJkMuQj5QHi_J4xIyWguJN2FMWAulzKQMPQjkz2VYo85x2zIsxAygXM6Tx7_sKfz8es6TJft4Xg9f8aPW5JJTLikGaY_nKNXsg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2091279301</pqid></control><display><type>article</type><title>INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM</title><source>Access via ProQuest (Open Access)</source><creator>Ghafil, Firas ; Anuta, Valentina ; Sarbu, Iulian ; Toderescu, Corina Dalia ; Mircioiu, Ion</creator><creatorcontrib>Ghafil, Firas ; Anuta, Valentina ; Sarbu, Iulian ; Toderescu, Corina Dalia ; Mircioiu, Ion</creatorcontrib><description>Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properties were prepared. For the quantitative assay of mebendazole a HPLC-UV method was developed and validated. Bioavailability was estimated by means of the in-vitro release kinetics using USP Apparatus 2, in Fasting State Simulated Intestinal Fluid (FaSSIF). Release of mebendazole in FaSSIF was poor (less than 10 % within 2 hours). Dissolution could be described by Higuchi law and Peppas law in both the swelling phase and post-errosion-disintegration phase, suggesting a diffusion controlled release. Both rate and extent of release increased with concentration of croscarmellose predicting a better bioavailability of mebendazole from the croscarmellose containing tablets.Keywords: mebendazole, croscarmellose, in vitro release, FaSSIF, intestinal suprasaturation</description><identifier>ISSN: 1584-2363</identifier><identifier>EISSN: 1842-7963</identifier><language>eng</language><publisher>Arad: "Vasile Goldis" Western University Arad, Romania</publisher><subject>Bioavailability ; Chromatography ; Classification ; Controlled release ; Dissolution ; Drug delivery systems ; Experiments ; High-performance liquid chromatography ; International conferences ; Intestine ; Mebendazole ; Methods ; Pharmaceutical industry ; Quantitative analysis ; Sodium ; Tablets</subject><ispartof>Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții, 2017-01, Vol.27 (1), p.39-46</ispartof><rights>Copyright "Vasile Goldis" Western University Arad, Romania Jan-Mar 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2091279301/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2091279301?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,25753,37012,44590,75126</link.rule.ids></links><search><creatorcontrib>Ghafil, Firas</creatorcontrib><creatorcontrib>Anuta, Valentina</creatorcontrib><creatorcontrib>Sarbu, Iulian</creatorcontrib><creatorcontrib>Toderescu, Corina Dalia</creatorcontrib><creatorcontrib>Mircioiu, Ion</creatorcontrib><title>INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM</title><title>Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții</title><description>Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properties were prepared. For the quantitative assay of mebendazole a HPLC-UV method was developed and validated. Bioavailability was estimated by means of the in-vitro release kinetics using USP Apparatus 2, in Fasting State Simulated Intestinal Fluid (FaSSIF). Release of mebendazole in FaSSIF was poor (less than 10 % within 2 hours). Dissolution could be described by Higuchi law and Peppas law in both the swelling phase and post-errosion-disintegration phase, suggesting a diffusion controlled release. Both rate and extent of release increased with concentration of croscarmellose predicting a better bioavailability of mebendazole from the croscarmellose containing tablets.Keywords: mebendazole, croscarmellose, in vitro release, FaSSIF, intestinal suprasaturation</description><subject>Bioavailability</subject><subject>Chromatography</subject><subject>Classification</subject><subject>Controlled release</subject><subject>Dissolution</subject><subject>Drug delivery systems</subject><subject>Experiments</subject><subject>High-performance liquid chromatography</subject><subject>International conferences</subject><subject>Intestine</subject><subject>Mebendazole</subject><subject>Methods</subject><subject>Pharmaceutical industry</subject><subject>Quantitative analysis</subject><subject>Sodium</subject><subject>Tablets</subject><issn>1584-2363</issn><issn>1842-7963</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNotjc1OwzAQhCMEElXpO1jiSlD809g-uonTruQ4Uuwg4FLVaXKoEC1N-yy8Lkawl5ndGX17k8ywYCTlMqe30S8FSwnN6X2ymKZDFodKIjmbJd9gi1YrB3aN_EajFTTqRRkwagUG_BtqKlTrlbalem-MRgDPCGxlOm0L_RsWbeMK1dbamMbFi0UlONeYzkP0rfL6CelXr61HypaRVWyUBVdHCnJQdyY2yrh47TxYZWKjhK5-SO7G3cc0LP51nvhK-2KTmmYNhTLpSYpLylk_jJkMuQj5QHi_J4xIyWguJN2FMWAulzKQMPQjkz2VYo85x2zIsxAygXM6Tx7_sKfz8es6TJft4Xg9f8aPW5JJTLikGaY_nKNXsg</recordid><startdate>20170101</startdate><enddate>20170101</enddate><creator>Ghafil, Firas</creator><creator>Anuta, Valentina</creator><creator>Sarbu, Iulian</creator><creator>Toderescu, Corina Dalia</creator><creator>Mircioiu, Ion</creator><general>"Vasile Goldis" Western University Arad, Romania</general><scope>8FE</scope><scope>8FH</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>BYOGL</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>HCIFZ</scope><scope>LK8</scope><scope>M7P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope></search><sort><creationdate>20170101</creationdate><title>INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM</title><author>Ghafil, Firas ; Anuta, Valentina ; Sarbu, Iulian ; Toderescu, Corina Dalia ; Mircioiu, Ion</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p98t-74cef09b68b6e27cd24299436893abfb17959b2becf49c398d17714e60bb08163</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Bioavailability</topic><topic>Chromatography</topic><topic>Classification</topic><topic>Controlled release</topic><topic>Dissolution</topic><topic>Drug delivery systems</topic><topic>Experiments</topic><topic>High-performance liquid chromatography</topic><topic>International conferences</topic><topic>Intestine</topic><topic>Mebendazole</topic><topic>Methods</topic><topic>Pharmaceutical industry</topic><topic>Quantitative analysis</topic><topic>Sodium</topic><topic>Tablets</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ghafil, Firas</creatorcontrib><creatorcontrib>Anuta, Valentina</creatorcontrib><creatorcontrib>Sarbu, Iulian</creatorcontrib><creatorcontrib>Toderescu, Corina Dalia</creatorcontrib><creatorcontrib>Mircioiu, Ion</creatorcontrib><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>ProQuest Natural Science Collection</collection><collection>East Europe, Central Europe Database</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>ProQuest Central Student</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>ProQuest Biological Science Journals</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><jtitle>Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ghafil, Firas</au><au>Anuta, Valentina</au><au>Sarbu, Iulian</au><au>Toderescu, Corina Dalia</au><au>Mircioiu, Ion</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM</atitle><jtitle>Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții</jtitle><date>2017-01-01</date><risdate>2017</risdate><volume>27</volume><issue>1</issue><spage>39</spage><epage>46</epage><pages>39-46</pages><issn>1584-2363</issn><eissn>1842-7963</eissn><abstract>Objective of the research was the developing of tablets with increased rate and extent of release of mebendazole in intestine in order to improve its bioavailability and pharmacokinetic profile. Three solid formulations containing 1%, 2% and 3 % croscarmellose sodium, with superdisintegrant properties were prepared. For the quantitative assay of mebendazole a HPLC-UV method was developed and validated. Bioavailability was estimated by means of the in-vitro release kinetics using USP Apparatus 2, in Fasting State Simulated Intestinal Fluid (FaSSIF). Release of mebendazole in FaSSIF was poor (less than 10 % within 2 hours). Dissolution could be described by Higuchi law and Peppas law in both the swelling phase and post-errosion-disintegration phase, suggesting a diffusion controlled release. Both rate and extent of release increased with concentration of croscarmellose predicting a better bioavailability of mebendazole from the croscarmellose containing tablets.Keywords: mebendazole, croscarmellose, in vitro release, FaSSIF, intestinal suprasaturation</abstract><cop>Arad</cop><pub>"Vasile Goldis" Western University Arad, Romania</pub><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1584-2363
ispartof Studia Universitatis "Vasile Goldiș". Seria ș̦tiințele vieții, 2017-01, Vol.27 (1), p.39-46
issn 1584-2363
1842-7963
language eng
recordid cdi_proquest_journals_2091279301
source Access via ProQuest (Open Access)
subjects Bioavailability
Chromatography
Classification
Controlled release
Dissolution
Drug delivery systems
Experiments
High-performance liquid chromatography
International conferences
Intestine
Mebendazole
Methods
Pharmaceutical industry
Quantitative analysis
Sodium
Tablets
title INCREASING THE BIOAVALILABILITY OF MEBENDAZOLE II. INFLUENCE OF CROSCARMELLOSE ON DISSOLUTION RATE, EXTENT AND MECHANISM IN SIMULATED INTESTINAL MEDIUM
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T09%3A11%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=INCREASING%20THE%20BIOAVALILABILITY%20OF%20MEBENDAZOLE%20II.%20INFLUENCE%20OF%20CROSCARMELLOSE%20ON%20DISSOLUTION%20RATE,%20EXTENT%20AND%20MECHANISM%20IN%20SIMULATED%20INTESTINAL%20MEDIUM&rft.jtitle=Studia%20Universitatis%20%22Vasile%20Goldi%C8%99%22.%20Seria%20%C8%99%CC%A6tiin%C8%9Bele%20vie%C8%9Bii&rft.au=Ghafil,%20Firas&rft.date=2017-01-01&rft.volume=27&rft.issue=1&rft.spage=39&rft.epage=46&rft.pages=39-46&rft.issn=1584-2363&rft.eissn=1842-7963&rft_id=info:doi/&rft_dat=%3Cproquest%3E2091279301%3C/proquest%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p98t-74cef09b68b6e27cd24299436893abfb17959b2becf49c398d17714e60bb08163%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2091279301&rft_id=info:pmid/&rfr_iscdi=true